| 
Description of Research: Daniel Kaul
INFECTIONS IN TRANSPLANT PATIENTS
Dr. Kaul directs the Transplant Infectious Disease
Service that provides inpatient and outpatient consultation
for patients who have received either solid organ
or stem cell transplants. We also work closely with
the various transplant groups preparing prophylactic
and treatment guidelines. Research interests include
the epidemiology of opportunistic infections after
solid organ transplantation and the diagnosis and
management of viral and other opportunistic infections
after stem cell transplantation.
HIV/AIDS
Dr. Kaul is a member of the HIV/AIDS Treatment Program
and spent two years training specifically in this
area and has been a principal investigator on phase
II, III, and IV multi-center trials of antiretroviral
agents. Research interests include clinical use of
antiretroviral therapies, immune reconstitution disease,
and resistance to antiretroviral agents.
RECENT PUBLICATIONS
Kaul DR, Jordan, M. Diffuse Infiltrative Lymphocytosis
Syndrome in an HIV-Positive Patient. Infections in
Medicine 2006 September, 23 (9): 412-414.
Kaul DR, Flanders SA, Beck JM, Saint S. The incidence,
etiology, risk factors, and outcome of hospital-acquired
fever: A systematic, evidence-based review. Journal
of General Internal Medicine 2006, 21 (11): 1184-87.
Safdar N, Kaul DR, Saint S. Into the Woods. New England
Journal of Medicine 2007, 356 (9): 943-947
Kaul DR, Orringer MB, Saint S, Jones SR. The Drenched
Doctor. New England Journal of Medicine 2007, 356
(18): 1871-1876.
Savona MR, Newton D, Frame D, Levine JE, Mineishi
S, Kaul DR. Low Dose Cidofovir Treatment of BK Virus
Associated Hemorrhagic Cystitis in Recipients of Hematopoietic
Stem Cell Transplants. Bone Marrow Transplantation
2007, Jun;39(12):783-7
Riddell J IV, Kaul DR, Karakousis PC, Gallant JE,
Mitty J, Kazanjian PH. Mycobacterium avium complex
immune reconstitution inflammatory syndrome: Long
term outcomes - art. no. 50. J Translat Med 5: 50,
2007.
Nicolasora NP, Reddy P, Kaul DR. Biopsy-proven adenoviral
diarrhea responding to low-dose cidofovir. Transpl
Infect Dis eFIRST date: 20 FEB 2008.
Safdar N, Abad CL, Kaul DR, Jarrard D, Saint S. An
unintended consequence. N Engl J Med 358 (14): 1496-1501,
2008.
Nicolasora N, Kaul DR. Infectious disease emergencies.
Med Clin N Amer 92 (2): 427-441, 2008.
|
